Skip to main content
Ipsen logo

Ipsen — Investor Relations & Filings

Ticker · IPN ISIN · FR0010259150 LEI · 549300M6SGDPB4Z94P11 PA Manufacturing
Open in API
Filings indexed 1,378 across all filing types
Latest filing 2018-06-04 Transaction in Own Shar…
Country FR France
Listing PA IPN

About Ipsen

https://www.ipsen.com/

Ipsen is a global biopharmaceutical company focused on innovation and specialty care. The company develops and commercializes transformative medicines to address high unmet medical needs in three key therapeutic areas: oncology, rare diseases, and neuroscience. By leveraging its specialized expertise and strategic partnerships, Ipsen aims to accelerate the development of new therapies and improve health outcomes for patients worldwide. Its strategy is centered on advancing science with purpose to bring innovative treatments from research and development to the market.

Recent filings

Filing Released Lang Actions
Rachat d'actions / Contrat de liquidité Descriptif du programme de rachat
Transaction in Own Shares Classification · 98% confidence The document is a press release dated June 4, 2018, announcing that Ipsen has initiated a share repurchase program (rachat d'actions) to cover employee stock plans. The core subject is the company buying back its own shares. This directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS), which covers share repurchase programs.
2018-06-04 French
Communicated under the obligation to provide permanent information / Other communications
AGM Information Classification · 99% confidence The document explicitly details the proceedings and resolutions passed during the 'Combined Shareholders' Meeting of IPSEN S.A. held on 30 May 2018'. Key elements include the approval of resolutions, dividend distribution, and the renewal/appointment of board directors. This content directly relates to the formal business conducted at an Annual General Meeting (AGM). Therefore, the appropriate classification is AGM Information (AGM-R). The document is not a proxy statement (PSI) or a declaration of voting results (DVA), but rather a summary report of the meeting itself.
2018-05-30 English
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
AGM Information Classification · 99% confidence The document is titled "Assemblée Générale Mixte des Actionnaires de la société IPSEN S.A. du 30 mai 2018" (Mixed General Meeting of Shareholders of IPSEN S.A. of May 30, 2018). It explicitly details the outcomes of this meeting, including the approval of resolutions, the distribution of a dividend (€1.00 per share), and changes/renewals in the Board of Directors. This content directly relates to the proceedings and outcomes of an Annual General Meeting (AGM). Therefore, the appropriate classification is AGM Information (AGM-R).
2018-05-30 French
Share buybacks / Liquidity contracts Description of share buyback program
Transaction in Own Shares Classification · 98% confidence The document is titled 'Description of the regulatory framework of the share repurchase program proposed by the Board of Directors to be approved at the Combined Shareholders' Meeting on 30 May 2018 (14th resolution)'. It details the objectives, characteristics, maximum amount, and duration of a proposed share repurchase program, which is a specific type of capital structure change or transaction in own shares. The text explicitly discusses the authorization for the Company to repurchase its own shares and the details of that proposed program. This aligns directly with the definition of 'Transaction in Own Shares' (POS), which covers share repurchase programs. While it relates to capital (CAP), the specific focus on the mechanics and authorization of buying back shares makes POS the most precise classification.
2018-05-30 English
Rachat d'actions / Contrat de liquidité Descriptif du programme de rachat
Transaction in Own Shares Classification · 98% confidence The document is titled "Descriptif du cadre réglementaire du programme de rachat d'actions soumis par le Conseil d'administration à l'approbation de l'Assemblée Générale Mixte des actionnaires du 30 mai 2018 (14ème résolution)". It details the objectives, modalities, maximum price, and duration for a proposed share repurchase program, which is being submitted for shareholder approval at the AGM on May 30, 2018. The core subject is the company's plan to buy back its own shares. This directly corresponds to the definition of 'Transaction in Own Shares' (POS). Although it relates to an AGM resolution, the content is specifically about the share repurchase mechanics, making POS a more precise classification than AGM-R or a general regulatory filing.
2018-05-30 French
Communicated under the obligation to provide permanent information / Other communications
Regulatory Filings Classification · 90% confidence The document is explicitly titled "PRESS RELEASE" and announces a strategic partnership and licensing agreement between Ipsen and MD Anderson for a pre-clinical oncology drug candidate. It details the collaboration structure (MD Anderson handles Phase I, Ipsen handles further development/commercialization) and includes quotes from executives. This type of announcement, detailing a significant business development (a drug development partnership), does not fit the specific definitions for financial reports (10-K, IR, ER), governance documents (CGR, DEF 14A), or shareholder actions (DIV, DVA). It is a material business event announcement. Since there is no specific category for 'Partnership Announcement' or 'Business Development,' and it is not a standard regulatory filing like a 10-K or an earnings release, the most appropriate fallback category is 'Regulatory Filings' (RNS), which serves as a general category for significant, non-standard corporate announcements that are typically released publicly via press release.
2018-05-29 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.